- call +1-201-465-4211
- email sales@mrinsights.biz
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
In the last several years, global stem cell therapy market developed fast at a average growth rate of 46.81%. In 2017, the global stem cell therapy market size was 235 million USD, and the market is expected to be 277 million USD.
On the basis of therapeutic application, the global stem cell therapy market is segmented into Musculoskeletal Disorder, Wounds & Injuries, Cornea, Cardiovascular Diseases, and other applications. The musculoskeletal disorders and Wounds & Injuries are expected to dominated the market.
According to this study, over the next five years the Stem Cell Therapy market will register a 20.7% CAGR in terms of revenue, the global market size will reach US$ 710 million by 2024, from US$ 280 million in 2019. In particular, this report presents the global revenue market share of key companies in Stem Cell Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Stem Cell Therapy market by product type, application, key companies and key regions.
This study considers the Stem Cell Therapy value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Autologous
Allogeneic
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Musculoskeletal Disorder
Wounds & Injuries
Cornea
Cardiovascular Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Molmed
Takeda (TiGenix)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Stem Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Stem Cell Therapy market by identifying its various subsegments.
Focuses on the key global Stem Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Stem Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Stem Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Stem Cell Therapy Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Stem Cell Therapy Market Size 2014-2024
2.1.2 Stem Cell Therapy Market Size CAGR by Region
2.2 Stem Cell Therapy Segment by Type
2.2.1 Autologous
2.2.2 Allogeneic
2.3 Stem Cell Therapy Market Size by Type
2.3.1 Global Stem Cell Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Stem Cell Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Stem Cell Therapy Segment by Application
2.4.1 Musculoskeletal Disorder
2.4.2 Wounds & Injuries
2.4.3 Cornea
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 Stem Cell Therapy Market Size by Application
2.5.1 Global Stem Cell Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Stem Cell Therapy Market Size Growth Rate by Application (2014-2019)
3 Global Stem Cell Therapy by Players
3.1 Global Stem Cell Therapy Market Size Market Share by Players
3.1.1 Global Stem Cell Therapy Market Size by Players (2017-2019)
3.1.2 Global Stem Cell Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Stem Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Stem Cell Therapy by Regions
4.1 Stem Cell Therapy Market Size by Regions
4.2 Americas Stem Cell Therapy Market Size Growth
4.3 APAC Stem Cell Therapy Market Size Growth
4.4 Europe Stem Cell Therapy Market Size Growth
4.5 Middle East & Africa Stem Cell Therapy Market Size Growth
5 Americas
5.1 Americas Stem Cell Therapy Market Size by Countries
5.2 Americas Stem Cell Therapy Market Size by Type
5.3 Americas Stem Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Stem Cell Therapy Market Size by Countries
6.2 APAC Stem Cell Therapy Market Size by Type
6.3 APAC Stem Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Stem Cell Therapy by Countries
7.2 Europe Stem Cell Therapy Market Size by Type
7.3 Europe Stem Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Stem Cell Therapy by Countries
8.2 Middle East & Africa Stem Cell Therapy Market Size by Type
8.3 Middle East & Africa Stem Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Stem Cell Therapy Market Forecast
10.1 Global Stem Cell Therapy Market Size Forecast (2019-2024)
10.2 Global Stem Cell Therapy Forecast by Regions
10.2.1 Global Stem Cell Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Stem Cell Therapy Forecast by Type
10.8 Global Stem Cell Therapy Forecast by Application
11 Key Players Analysis
11.1 Osiris Therapeutics
11.1.1 Company Details
11.1.2 Stem Cell Therapy Product Offered
11.1.3 Osiris Therapeutics Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Osiris Therapeutics News
11.2 NuVasive
11.2.1 Company Details
11.2.2 Stem Cell Therapy Product Offered
11.2.3 NuVasive Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 NuVasive News
11.3 Chiesi Pharmaceuticals
11.3.1 Company Details
11.3.2 Stem Cell Therapy Product Offered
11.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Chiesi Pharmaceuticals News
11.4 JCR Pharmaceutical
11.4.1 Company Details
11.4.2 Stem Cell Therapy Product Offered
11.4.3 JCR Pharmaceutical Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 JCR Pharmaceutical News
11.5 Pharmicell
11.5.1 Company Details
11.5.2 Stem Cell Therapy Product Offered
11.5.3 Pharmicell Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Pharmicell News
11.6 Medi-post
11.6.1 Company Details
11.6.2 Stem Cell Therapy Product Offered
11.6.3 Medi-post Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Medi-post News
11.7 Anterogen
11.7.1 Company Details
11.7.2 Stem Cell Therapy Product Offered
11.7.3 Anterogen Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Anterogen News
11.8 Molmed
11.8.1 Company Details
11.8.2 Stem Cell Therapy Product Offered
11.8.3 Molmed Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Molmed News
11.9 Takeda (TiGenix)
11.9.1 Company Details
11.9.2 Stem Cell Therapy Product Offered
11.9.3 Takeda (TiGenix) Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Takeda (TiGenix) News
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Stem Cell Therapy
Figure Stem Cell Therapy Report Years Considered
Figure Market Research Methodology
Figure Gl
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
